Diagnostic Value of FPSAD and PI-RADS v2.1 for Clinically Significant Prostate Cancer in Patients with tPSA Levels of 4-10 ng/mL. [PDF]
Guo W, Tan P, He Y, Yi X.
europepmc +1 more source
Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT-based comprehensive radiographic scheme and cognitive fusion targeted biopsy. [PDF]
Zhou Y, Qiu R, Dou M, Bi W, Yu Y.
europepmc +1 more source
Multimodal urinary biomarker panel achieves superior prostate cancer detection accuracy and reduces unnecessary biopsies. [PDF]
Panahi Y +3 more
europepmc +1 more source
A small step forward\u2026 - corporate governance rating 2003 for Polish listed companies [PDF]
Dzierzanowski, Maciej +2 more
core
Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug Discovery. [PDF]
Liu W +5 more
europepmc +1 more source
The diagnostic value of prostate health index combined with soluble e-cadherin for prostate cancer. [PDF]
Ahamed Y +4 more
europepmc +1 more source
Evaluation of a PSA and transrectal prostate ultrasound video-based machine learning model as a tool for prostate cancer diagnosis. [PDF]
Du Y +5 more
europepmc +1 more source
Multimodal integration of [<sup>18</sup>F]PSMA-1007 PET/CT semiquantitative parameters and clinicopathological data for predicting prostate cancer metastasis. [PDF]
Yang J +6 more
europepmc +1 more source
Phyllodes-predominant prostatic stromal sarcoma concurrent with prostate adenocarcinoma: a case report and literature review. [PDF]
Lian H +6 more
europepmc +1 more source

